Chorionic villus sampling for beta-thalassemia: The first report of experience in Iran

Prenatal Diagnosis

Volumn 26, Issue 12, 2006, Pages 1131-1136

  Akhlaghpoor, Shahram ^a  

^a Novin Medical Radiation Institute   (Iran)

Author keywords

Beta thalassemia; Chorionic villus sampling; Prenatal diagnosis

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BETA THALASSEMIA; BLEEDING; CHORION VILLUS SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FETUS WASTAGE; HEMATOMA; HUMAN; IRAN; MAJOR CLINICAL STUDY; OLIGOHYDRAMNIOS; POPULATION RESEARCH; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SPOTTING; SYNCOPE;

ABORTION, INDUCED; ADOLESCENT; ADULT; BETA-THALASSEMIA; CHORIONIC VILLI SAMPLING; FEMALE; FETAL DISEASES; HUMANS; IRAN; ISLAM; NATIONAL HEALTH PROGRAMS; PREGNANCY;

EID: 33845582115     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1572     Document Type: Article

References (31)

1. Ahmed S, Saleem M, Sultana N, et al. 2000. Prenatal diagnosis of beta-thalassaemia in Pakistan: experience in a Muslim country. Prenat Diagn 20(5): 378-383.
2. Akhlaghpoor S, Hosseinipoor T. 2005. The effect of chorionic villus sampling on fetal heart rate. Fetal Diagn Ther 20: 116-120.
3. Alwan A, Modell B, Czeizel A, Hammamy H. 1997. Community Control of Genetic and Congenital Disorders, WHO EMRO Technical Publication Series: 24.
4. Brambati B, Lanzani A, Oldrini A. 1988. Transabdominal chorionic villus sampling. Clinical experience of 1159 cases. Prenat Diagn 8(8): 609-617.
5. Brambati B, Tului L, Camurri L, Guercilena S. 2002. Early second trimester (13 to 20 weeks) transabdominal chorionic villus sampling (TA-CVS): a safe and alternative method for both high and low risk populations. Prenat Diagn 22(10): 907-913.
6. Brun JL, Mangione R, Gangbo F, et al. 2003. Feasibility, accuracy and safety of chorionic villus sampling: a report of 10741 cases. Prenat Diagn 23(4): 295-301.
7. Cederholm M, Haglund B, Axelsson O. 2003. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG 110(4): 392-399.
8. Chandran R, Ainoon O, Anson I, Anne J, Cheong SK. 1993. First trimester prenatal diagnosis of beta-thalassaemia following chorionic villus sampling. Med J Malaysia 48(3): 341-344.
9. Christianson A, Streely A, Darr A. 2004. Lessons from thalassemia screening in Iran. BMJ 329: 1115-1117.
10. Embury SH. 1995. Advances in the prenatal and molecular diagnosis of the hemoglobinopathies and thalassemias. Hemoglobin 19(5): 237-261.
11. Fucharoen G, Tungwiwat W, Ratanasiri T, Sanchaisuriya K, Fucharoen S. 2003. Prenatal detection of fetal hemoglobin E gene from maternal plasma. Prenat Diagn 23(5): 393-396.
12. Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. 2003. Molecular spectrum of alpha-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol 74(2): 99-103.
13. Hogge WA, Schonberg SA, Golbus MS. 1986. Chorionic villus sampling: experience of the first 1000 cases. Am J Obstet Gynecol 154(6): 1249-1252.
14. Hsieh TT, Lee JD, Kuo DM, et al. 1989. Perinatal outcome of chorionic villus sampling versus amniocentesis. Taiwan Yi Xue Hui Za Zhi Sep 88(9): 894-899.
15. Jackson LG, Zachary JM, Fowler SE, et al. 1992. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med 327(9): 594-598.
16. Karimi M, Rasekhi AR. 2002. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Pars Province, Iran. Haematologia (Budap) 32(2): 129-133.
17. Karimi M, Yarmohammadi H, Farjadian S, et al. 2002. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G->A) is the prevalent thalassemia intermedia allele. Hemoglobin 26(2): 147-154.
18. Khan SN, Riazuddin S. 1998. Molecular characterization of beta-thalassemia in Pakistan. Hemoglobin 22(4): 333-345.
19. Kuliev A, Jackson L, Froster U, et al. 1996. Chorionic villus sampling safety. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel-Aviv. Israel. May 21. 1994. Am J Obstet Gynecol 174(3): 807-811.
20. Mahboudi F. Zeinali S, Merat A. et al. 1996. The molecular basis of beta -thalassemia mutations in Pars Province, Iran. Irn J Med Sci 21: 99-104.
21. Merat A, Haghshenas M, Mostafavi Pour Z. et al. 1993. Beta-Thalassemia in Southwestern Iran. Hemoglobin 17(5): 427-437.
22. Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. 2001. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin 25(3): 285-296.
23. Noori-Daloii MR, Moazami N, Farhangi S, et al. 1994. Beta-Thalassemia in Iran: a high incidence of the nonsense codon 39 mutation on the island of Queshm. Hemoglobin 18(6): 449-453.
24. Nozari G, Rahbar S, Golshaiyzan A. 1995. Rahmanzadeh, S. molecular analyses of beta-thalassemia in Iran. Hemoglobin 19(6): 425-431.
25. Papp C, Beke A, Mezei G, Toth-Pal E, Papp Z. 2002. Chorionic villus sampling: a 15-year experience. Fetal Diagn Ther 17(4): 218-227.
26. Samavat A, Modell B. 2004. Iranian national thalassaemia screening programme. BMJ 329: 1134-1137.
27. Saura R, Horovitz J, Grison O, et al. 1991. Evaluation of the risks of transabdominal chorionic villus sampling. 600 Cases J Gynecol Obstet Biol Reprod (Paris) 20(4): 496-500.
28. Scott F, Peters H, Boogert T, et al. 2002. The loss rates for invasive prenatal testing in a specialised obstetric ultrasound practice. Aust N Z J Obstet Gynaecol Feb 42(1): 55-58.
29. Tuzmen S, Tadmouri GO, Ozer A, et al. 1996. Prenatal diagnosis of beta-thalassaemia and sickle cell anaemia in Turkey. Primat Diagn 16(3): 252-258.
30. Wapner RJ. 1997. Chorionic villus sampling. Obstet Gynecol Clin North Am 24(1): 83-110.
31. Zahed L, Bou-Dames J. 1997. Acceptance of first-trimesier prenatal diagnosis for the haemoglobinopathies in Lebanon. Prenat Diagn 17(5): 423-428.